Document Details

Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Diffusion Pharmaceuticals Inc. (Charlottesville, VA)
Event Date 12/11/2019
Filing Date 12/13/2019

Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Disclosure; and Financial Statements and Exhibits.

File Section(s)

  1. FORM 8-K
  2. EXHIBIT 4.1
  3. EXHIBIT 4.2
  4. EXHIBIT 5.1
  5. EXHIBIT 10.1
  6. EXHIBIT 10.2
  7. EXHIBIT 99.1
  8. EXHIBIT 99.2

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.